Suppr超能文献

Fontan 患者初始心力衰竭咨询后的结局。

Outcomes after initial heart failure consultation in Fontan patients.

机构信息

Lucile Packard Children's Hospital at Stanford, Palo Alto, CA, USA.

Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

出版信息

Cardiol Young. 2024 May;34(5):989-996. doi: 10.1017/S1047951123003852. Epub 2023 Nov 28.

Abstract

BACKGROUND

Patients with Fontan failure are high-risk candidates for heart transplantation and other advanced therapies. Understanding the outcomes following initial heart failure consultation can help define appropriate timing of referral for advanced heart failure care.

METHODS

This is a survey study of heart failure providers seeing any Fontan patient for initial heart failure care. Part 1 of the survey captured data on clinical characteristics at the time of heart failure consultation, and Part 2, completed 30 days later, captured outcomes (death, transplant evaluation outcome, and other interventions). Patients were classified as "too late" (death or declined for transplant due to being too sick) and/or "care escalation" (ventricular assist device implanted, inotrope initiated, and/or listed for transplant), within 30 days. "Late referral" was defined as those referred too late and/or had care escalation.

RESULTS

Between 7/2020 and 7/2022, 77 Fontan patients (52% inpatient) had an initial heart failure consultation. Ten per cent were referred too late (6 were too sick for heart transplantation with one subsequent death, and two others died without heart transplantation evaluation, within 30 days), and 36% had care escalation (21 listed ± 5 ventricular assist device implanted ± 6 inotrope initiated). Overall, 42% were late referrals. Heart failure consultation < 1 year after Fontan surgery was strongly associated with late referral (OR 6.2, 95% CI 1.8-21.5, p=0.004).

CONCLUSIONS

Over 40% of Fontan patients seen for an initial heart failure consultation were late referrals, with 10% dying or being declined for transplant within a month of consultation. Earlier referral, particularly for those with heart failure soon after Fontan surgery, should be encouraged.

摘要

背景

Fontan 衰竭患者是心脏移植和其他先进治疗的高危候选者。了解初始心力衰竭咨询后的结果有助于确定晚期心力衰竭治疗的适当转诊时机。

方法

这是一项对接受初始心力衰竭治疗的任何 Fontan 患者进行心力衰竭治疗的调查研究。调查的第一部分记录了心力衰竭咨询时的临床特征数据,第二部分在 30 天后完成,记录了结果(死亡、移植评估结果和其他干预措施)。患者在 30 天内被分为“太晚”(因病情太重而死亡或拒绝移植)和/或“护理升级”(植入心室辅助装置、开始使用正性肌力药物和/或列入移植名单)。“延迟转诊”是指那些转诊太晚和/或护理升级的患者。

结果

在 2020 年 7 月至 2022 年 7 月期间,77 名 Fontan 患者(52%为住院患者)接受了初始心力衰竭咨询。10%的患者转诊太晚(6 名因病情太重无法进行心脏移植,其中 1 名随后死亡,另外 2 名死亡前未进行心脏移植评估,在 30 天内),36%的患者护理升级(21 名列入±5 名植入心室辅助装置±6 名开始使用正性肌力药物)。总体而言,42%的患者是延迟转诊。Fontan 手术后<1 年进行心力衰竭咨询与延迟转诊密切相关(比值比 6.2,95%可信区间 1.8-21.5,p=0.004)。

结论

超过 40%的 Fontan 患者在接受初始心力衰竭咨询时被延迟转诊,其中 10%在咨询后一个月内死亡或因病情太重而被拒绝移植。应鼓励更早的转诊,特别是对于那些在 Fontan 手术后不久出现心力衰竭的患者。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验